Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy

Gene Therapy

Volumn 7, Issue 12, 2000, Pages 1005-1010

  Stegman, L D ^a   Rehemtulla, A ^a   Hamstra, D A ^a   Rice, D J ^a   Jonas, S J ^a   Stout, K L ^a   Chenevert, T L ^a   Ross, B D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

5 fluorocytosine; Diffusion MRI; Gene therapy; Glioma; Yeast cytosine deaminase

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CHEMOSENSITIVITY; CONTROLLED STUDY; DIFFUSION; GENE THERAPY; GLIOMA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SACCHAROMYCES CEREVISIAE;

ANIMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0034088225     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301199     Document Type: Article

References (32)

1. Stejskal E, Tanner J. Spin diffusion measurements: spin-echoes in the presence of a time-dependent field gradient. J Chem Phys 1965; 42: 288-292.
2. Evelhoch JL et al. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia 2000; 2: 153-166.
3. Rowley H, Grant P, Roberts T. Diffusion MR imaging. Theory and applications. Neuroimag Clin N Am 1999; 9: 343-361.
4. Ross BD et al. Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Quart Magn Reson Biol Med 1994; 1: 89-106.
5. 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 1996; 73: 61-64.
6. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997; 3: 1457-1466.
7. Ross BD, Ben-Yoseph O, Chenevert TL. In vivo magnetic resonance imaging and spectroscopy: application to brain tumors. In: Bachelard HS (ed). Magnetic Resonance Spectroscopy and Imaging in Neurochemistry, vol 8. Plenum Press: New York, 1997, pp 145-178.
8. 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998; 58: 3791-3799.
9. Poptani H et al. Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther 1998; 5: 101-109.
10. Galons JP et al. Early increases in breast tumor xenograft water mobility in response to taxol therapy detected by non-invasive diffusion MRI. Neoplasia 1999; 1: 113-117.
11. Harris JD et al. Gene therapy for cancer using tumour-specific prodrug activation. Gene Therapy 1994; 1: 170-175.
12. Bourke RS et al. Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following intravenous injection in a primate. Cancer Res 1973; 33: 1735-1746.
13. Block E, Bennett J. Pharmacological studies with 5-fluorocytosine. Med Radiol (Mosk) 1974; 19: 476-482.
14. Pu AT, Robertson JM, Lawrence TS. Current status of radiation sensitization by fluoropyrimidines. Oncology 1995; 9: 707-714.
15. Penn RD et al. Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil. Appl Neurophysiol 1983; 46: 240-244.
16. Gerosa MA et al. Improved treatment of a brain-tumor model; part 2: sequential therapy with BCNU and 5-fluorouracil. J Neurosurg 1983; 58: 368-373.
17. Dong Y et al. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 1996; 7: 713-720.
18. Xu LF et al. Experimental treatment of brain tumor cells using CD suicide gene. Shih Yen Sheng Wu Hsueh Pao 1996; 29: 385-393.
19. Kim JH et al. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Cancer J Sci Am 1998; 4: 364-369.
20. Ge K et al. Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine. Int J Cancer 1997; 71: 675-679.
21. Wang ZH et al. 5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon. J Neurooncol 1998; 36: 219-229.
22. Aghi M et al. Synergistic anticancer effects of ganciclovir/ thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst 1998; 90: 370-380.
23. Erbs P, Exinger F, Jund R. Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans. Curr Genet 1997; 31: 1-6.
24. Hayden MS et al. Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae. Prot Exp Purif 1998; 12: 173-184.
25. Kievit E et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon carcinoma xenografts. Cancer Res 1998; 59: 1417-1421.
26. Chinnaiyan A et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 2000; 97: 1754-1759.
27. Stegman LD et al. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts in vivo with magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1999; 96: 9821-9826.
28. Niendorf T et al. Biexponential diffusion attenuation in various states of brain tissue: implication for diffusion-weighted MRI. Magn Res Med 1996; 36: 847-857.
29. Skehan P et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112.
30. Ross BD et al. Contributions of cell kill and post-reatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci USA 1998; 95: 7012-7017.
31. Wong E, Cox R, Song A. Optimized isotropic diffusion weighting. Magn Res Med 1995; 34: 139-143.
32. Burdette J, Elster A, Ricci P. Calculation of apparent diffusion coefficients (ADCs) in brain using two-point and six-point methods. J Comput Assist Tomogr 1998; 22: 792-794.